High mobility group box1 protein is involved in acute inflammation induced by Clostridium difficile toxin A

Acta Biochimica et Biophysica Sinica

Volumn 48, Issue 6, 2016, Pages 554-562

  Liu, Ji ^a   Zhang, Bei Lei ^a   Sun, Chun Li ^a   Wang, Jun ^b   Li, Shan ^a   Wang, Ju Fang ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^b Shenzhen Huada Gene Research Institute   (China)

Author keywords

Clostridium difficile toxin A; HMGB1; Ileal loop; Inflammation

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID; BACTERIAL TOXIN; ENTEROTOXIN; GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; HMGB1 PROTEIN, HUMAN; HMGB1 PROTEIN, MOUSE; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE; TLR4 PROTEIN, HUMAN; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DISEASE MODEL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMAN; INFLAMMATION; METABOLISM; MOUSE; PATHOLOGY; RAW 264.7 CELL LINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BACTERIAL TOXINS; CELL LINE; DISEASE MODELS, ANIMAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; FEMALE; GLYCYRRHIZIC ACID; HMGB1 PROTEIN; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MICE; RAW 264.7 CELLS; TOLL-LIKE RECEPTOR 4;

EID: 84979276989     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmw038     Document Type: Article

References (27)

1. Dingle T, Wee S, Mulvey GL, Greco A, Kitova EN, Sun JX, Lin SJ, et al. Functional properties of the carboxyl-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile. Glycobiology 2008, 18: 698-706.
2. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, Kuijper EJ, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010, 23: 529-549.
3. Bauer MP, van Dissel JT, Kuijper EJ. Clostridium difficile: controversies and approaches to management. Curr Opin Infect Dis 2009, 22: 517-524.
4. McFarland LV. Alternative treatments for Clostridium difficile disease: what really works? J Med Microbiol 2005, 54: 101-111.
5. Alcantara C, Stenson WF, Steiner TS, Guerrant RL. Role of inducible cyclooxygenase and prostaglandins in Clostridium difficile toxin A induced secretion and inflammation in an animal model. J Infect Dis 2001, 184: 648-652.
6. Yamada S, Maruyama I. HMGB1, a novel inflammatory cytokine. Clin Chim Acta 2007, 375: 36-42.
7. Andersson U, Erlandsson-Harris H. HMGB1 is a potent trigger of arthritis. J Intern Med 2004, 255: 344-350.
8. Wang H, Yang H, Tracey KJ. Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 2004, 255: 320-331.
9. Porto A, Palumbo R, Pieron M, Aprigliano G, Chiesa R, Sanvito F, Maseri A, et al. Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility protein box 1. FASEB J 2006, 20: E1-E9.
10. Vakkila J, Lotze MT. Inflammation and necrosis promote tumor growth. Nat Rev Immunol 2004, 4: 641-648.
11. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. Archive 2005, 201: 1135.
12. Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, Buss S, et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008, 117: 3216-3226.
13. Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, Fenton MJ, et al. HMGB1 signals through toll-like receptor (TLR4) and TLR2. Shock 2006, 26: 174-179.
14. Girard JP. A direct inhibitor of HMGB1 cytokine. Cell 2007, 14: 345-347.
15. Mollica L, Marchis FD, Spitaleri A, Dallacosta C, Pennacchini D, Zamai M, Agresti A, et al. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Cell 2007, 14: 431-441.
16. Ii M, Matsunaga N, Hazeki K, Nakamura K, Takashima K, Seya T, Hazeki O, et al. A novel cyclohexene derivative, ethyl (6R)-6- [N-(2-Chloro-4-fluorophenyl) sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Mol Pharmacol 2006, 69: 1288-1295.
17. Vivot K, Langlois A, Bietiger W, Dal S, Seyfritz E, Pinget M, Jeandidier N, et al. Pro-inflammatory and pro-oxidant status of pancreatic islet in vitro is controlled by TLR-4 and HO-1 pathways. PLoS One 2014, 9: e107656.
18. Chen RJ, Yuan HH, Zhang TY, Wang ZZ, Hu AK, Wu LL, Yang ZP, et al. Heme oxygenase-2 suppress TNF-α and IL6 expression via TLR4/MyD88-dependent signaling pathway in mouse cerebral vascular endothelial cells. Mol Neurobiol 2014, 50: 971-978.
19. SullivanNM, Pellett S, Wilkins TD. Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun 1982, 35: 1032-1040.
20. Kaur S, Vaishnavi C, Ray P, Kochhar R, Prasad KK. Effect of biotherapeutics on cyclosporin-induced Clostridium difficile infection in mice. J Gastroenterol Hepatol 2010, 25: 832-838.
21. Stros M. HMGB proteins: interactions with DNA and chromatin. Biochim Biophys Acta 2010, 1799: 101-113.
22. Chumbler NM, Farrow MA, Lapierre LA, Franklin JL, Haslam D, Goldenring JR, Lacy DB. Clostridium difficile toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism. PLoS Pathog 2012, 8: e1003072.
23. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999, 19: 5237-5246.
24. Sappington PL, Yang R, Yang H, Tracy KJ, Delude RL, Fink MP. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 2002, 123: 790-802.
25. Deng Y, Yang Z, Gao Y, Xu H, Zheng B, Jiang M, Xu J, et al. Toll-like receptor 4 mediates acute lung injury induced by high mobility group box-1. PLoS One 2013, 8: e64375.
26. Siemann M, Koch-Dorfler M, Rabenhorst G. Clostridium difficile associated diseases. The clinical courses of 18 fatal cases. Intensive Care Med 2000, 26: 416-421.
27. Ryan A, Lynch M, Smith SM, Amu S, Nel HJ, McCoy CE, Dowling JK, et al. A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins. PLoS Pathogens 2011, 7: e1002076.